What is the Volini Gel 30gm used for?

Volini Gel 30gm is a topical pain relief gel designed to alleviate muscle pain, sprains, and strains. Formulated with diclofenac diethylamine, a non-steroidal anti-inflammatory drug (NSAID), it effectively reduces inflammation and pain, providing targeted relief for discomfort associated with various physical activities and injuries.

Directions for use

Gently apply a thin layer of gel to the affected area and massage. Use up to 4 times daily.

Use of the Gel

The Volini Gel 30 gm (Diclofenac) is utilized to alleviate joint pain, back pain, neck pain, shoulder pain, as well as sprains and strains, offering targeted relief for a range of discomforts.

Working

Volini Gel 30 gm (Diclofenac) is an analgesic drug absorbed topically for relief from joint pain, muscle pain, injury-induced pain, back pain, sprains, strains, and to delay muscle soreness. Its topical application offers targeted relief for various sources of discomfort and helps alleviate muscle-related issues.

Drug Interaction

Some medications have been reported to interact with Volini Gel 1% w/w, potentially leading to adverse effects or impacting the effectiveness of the medication. It’s crucial to inform your doctor about any other medications or herbal supplements you are taking. Additionally, refrain from applying any other topical products while using this gel to avoid potential interactions that could cause allergic or inflammatory skin reactions.

Dosage

Volini Gel 30 gm is topically applied to treat various types of body pain. Available in different strengths and substitutes, it requires a prescription. Consultation with a doctor is essential for determining application frequency and duration due to variations in age and pain severity. Adults should use it at a fixed time as directed, while it is not recommended for pediatric use.

Overdosage

If applied more frequently than prescribed, you may experience symptoms of overdose. In such instances, promptly seek medical attention. Avoid excessive application of the gel as it will accumulate without providing additional therapeutic benefits.

Side Effects of Volini Gel 30 gm

The side effects of Volini Gel 30 gm may include allergic contact dermatitis, high blood pressure, mild cold or burning sensation at the application site, rashes, and anaphylactic reactions. It’s important to be aware of these potential effects and seek medical advice if necessary.

Safety advice

Volini Gel is contraindicated for individuals with hypersensitivity or allergic reactions, as well as for use in infants or children. It should not be applied to sunburnt skin, cuts, wounds, or other soft tissue injuries. Always consult your doctor for the best possible treatment and dosage adjustments, and to ensure that Volini Gel is safe and suitable for your specific condition before use.

Storage

Keep the Volini Gel in a cool, dark, and dry place at room temperature.

FAQs

1. Is Volini Gel safe for children?
Yes, Volini gel is safe for use by children above 8 years old, under adult supervision.

2. What are the active ingredients in volini gel?

The active ingredients in Volini Gel are:

Diclofenac Diethylamide: An anti-inflammatory agent that helps in reducing pain and inflammation.
Methyl Salicylate: A salicylate derivative that has analgesic and anti-inflammatory properties.
Menthol: An analgesic compound that provides a cooling sensation and helps in relieving pain.
Linseed Oil: A natural ingredient that helps in reducing inflammation and swelling.

3. Can volini gel be used for chronic pain relief?

While Volini Gel can be effective in relieving various types of pain, such as neck, back, joint, and muscle pain, it is not specifically designed for chronic pain relief. Chronic pain is typically long-lasting and may require ongoing medical management and treatment

Details about the manufacturer

Solrex Pharmaceuticals is a leading distributor and supplier of allopathic medicines, including tablets, capsules, and syrups, located in Baddi, Himachal Pradesh, India. They offer a range of products and services in the pharmaceutical sector.

-13%